title: Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen.
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Roquebert
authors.forename: Laurent
authors.initials: L
authors.lastname: Blum
authors.forename: Gilles
authors.initials: G
authors.lastname: Collin
authors.forename: Florence
authors.initials: F
authors.lastname: Damond
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Juliette
authors.initials: J
authors.lastname: Leleu
authors.forename: Sophie
authors.initials: S
authors.lastname: Matheron
authors.forename: Geneviève
authors.initials: G
authors.lastname: Chêne
authors.forename: Françoise
authors.initials: F
authors.lastname: Brun-Vézinet
authors.forename: Diane
authors.initials: D
authors.lastname: Descamps
mesh_terms: D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D019427:HIV Integrase / Q000235:genetics*; D019428:HIV Integrase Inhibitors / Q000627:therapeutic use*; D015498:HIV-2 / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011760:Pyrrolidinones / Q000627:therapeutic use*; D000068898:Raltegravir Potassium; D017211:Treatment Failure
chemical_list: D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D019427:HIV Integrase